SG11202110076PA - Method of introducing target-specific foreign gene - Google Patents
Method of introducing target-specific foreign geneInfo
- Publication number
- SG11202110076PA SG11202110076PA SG11202110076PA SG11202110076PA SG11202110076PA SG 11202110076P A SG11202110076P A SG 11202110076PA SG 11202110076P A SG11202110076P A SG 11202110076PA SG 11202110076P A SG11202110076P A SG 11202110076PA SG 11202110076P A SG11202110076P A SG 11202110076PA
- Authority
- SG
- Singapore
- Prior art keywords
- foreign gene
- specific foreign
- introducing target
- introducing
- target
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
- C12N15/90—Stable introduction of foreign DNA into chromosome
- C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
- C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/10—Immunoglobulins specific features characterized by their source of isolation or production
- C07K2317/14—Specific host cells or culture conditions, e.g. components, pH or temperature
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
Landscapes
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cell Biology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019070329 | 2019-04-02 | ||
| PCT/JP2020/014980 WO2020204055A1 (en) | 2019-04-02 | 2020-04-01 | Method of introducing target-specific foreign gene |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202110076PA true SG11202110076PA (en) | 2021-10-28 |
Family
ID=72668649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202110076PA SG11202110076PA (en) | 2019-04-02 | 2020-04-01 | Method of introducing target-specific foreign gene |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220170047A1 (en) |
| EP (1) | EP3950938A4 (en) |
| JP (1) | JPWO2020204055A1 (en) |
| KR (1) | KR102655024B1 (en) |
| CN (1) | CN113661238A (en) |
| AU (1) | AU2020252840A1 (en) |
| BR (1) | BR112021018313A2 (en) |
| CA (1) | CA3134705A1 (en) |
| IL (1) | IL286630A (en) |
| MX (1) | MX2021011903A (en) |
| SG (1) | SG11202110076PA (en) |
| TW (1) | TW202043478A (en) |
| WO (1) | WO2020204055A1 (en) |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2707189B1 (en) | 1993-07-09 | 1995-10-13 | Gradient Ass | Method for treating combustion residues and installation for implementing said method. |
| US6521419B1 (en) | 1998-09-22 | 2003-02-18 | Kanakaraju Koduri | Expression vectors containing hot spot for increased recombinant protein expression in transfected cells |
| WO2002020565A2 (en) | 2000-09-08 | 2002-03-14 | Universität Zürich | Collections of repeat proteins comprising repeat modules |
| CA2418835A1 (en) | 2000-10-16 | 2002-04-25 | Phylos, Inc. | Protein scaffolds for antibody mimics and other binding proteins |
| US20030157561A1 (en) | 2001-11-19 | 2003-08-21 | Kolkman Joost A. | Combinatorial libraries of monomer domains |
| WO2003029462A1 (en) | 2001-09-27 | 2003-04-10 | Pieris Proteolab Ag | Muteins of human neutrophil gelatinase-associated lipocalin and related proteins |
| US20050164301A1 (en) | 2003-10-24 | 2005-07-28 | Avidia Research Institute | LDL receptor class A and EGF domain monomers and multimers |
| CN1618955A (en) * | 2003-11-20 | 2005-05-25 | 中国人民解放军军事医学科学院生物工程研究所 | CHO/dhfr cell fixed point integrated expression system |
| DK2049564T3 (en) | 2006-08-02 | 2017-07-24 | Uab Res Found | METHODS AND COMPOSITIONS RELATED TO SOLUBLE MONOCLONAL VARIABLE Lymphocyte RECEPTORS WITH DEFINED ANTIGEN SPECIFICITY |
| WO2008151219A1 (en) | 2007-06-04 | 2008-12-11 | Regeneron Pharmaceuticals, Inc. | Enhanced expression and stability regions |
| JP2010210772A (en) | 2009-03-13 | 2010-09-24 | Dainippon Screen Mfg Co Ltd | Method of manufacturing liquid crystal display device |
| US20130034875A1 (en) * | 2009-10-01 | 2013-02-07 | Toto Ltd. | Dna construct, and process for production of recombinant cho cell using same |
| KR101999410B1 (en) * | 2011-04-05 | 2019-07-11 | 더 스크립스 리서치 인스티튜트 | Chromosomal landing pads and related uses |
| EP2711428A1 (en) * | 2012-09-21 | 2014-03-26 | Lonza Biologics plc. | Site-specific integration |
| KR102288857B1 (en) | 2013-12-20 | 2021-08-11 | 노파르티스 아게 | Novel eukaryotic cells and methods for recombinantly expressing a product of interest |
| JP6858559B2 (en) | 2014-08-20 | 2021-04-14 | 中外製薬株式会社 | Method for measuring viscosity of protein solution |
| EA037255B1 (en) | 2014-10-23 | 2021-02-26 | Регенерон Фармасьютикалз, Инк. | Novel cho integration sites and uses thereof |
| CN104818253B (en) * | 2015-03-24 | 2018-03-09 | 成都贝爱特生物科技有限公司 | Target transformation of site-directed integration Chinese hamster ovary celI system and application thereof |
| DE102015222931A1 (en) * | 2015-11-20 | 2017-05-24 | Continental Teves Ag & Co. Ohg | Arrangement for measuring a displacement path generated by braking force |
| TWI827531B (en) * | 2016-04-20 | 2024-01-01 | 美商再生元醫藥公司 | Compositions and methods for making antibodies based on use of expression-enhancing loci |
| JP7134868B2 (en) | 2016-04-20 | 2022-09-12 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | Compositions and methods for generating antibodies based on the use of enhanced expression loci |
| WO2018118901A1 (en) * | 2016-12-20 | 2018-06-28 | Development Center For Biotechnology | Targeted integration sites in chinese hamster ovary cell genome |
| EP3665291B1 (en) * | 2017-08-11 | 2021-10-06 | Boehringer Ingelheim International GmbH | Integration sites in cho cells |
-
2020
- 2020-04-01 KR KR1020217034905A patent/KR102655024B1/en active IP Right Grant
- 2020-04-01 SG SG11202110076PA patent/SG11202110076PA/en unknown
- 2020-04-01 TW TW109111209A patent/TW202043478A/en unknown
- 2020-04-01 AU AU2020252840A patent/AU2020252840A1/en active Pending
- 2020-04-01 BR BR112021018313A patent/BR112021018313A2/en unknown
- 2020-04-01 US US17/600,319 patent/US20220170047A1/en active Pending
- 2020-04-01 JP JP2021512163A patent/JPWO2020204055A1/ja active Pending
- 2020-04-01 MX MX2021011903A patent/MX2021011903A/en unknown
- 2020-04-01 WO PCT/JP2020/014980 patent/WO2020204055A1/en unknown
- 2020-04-01 CA CA3134705A patent/CA3134705A1/en active Pending
- 2020-04-01 EP EP20784329.3A patent/EP3950938A4/en active Pending
- 2020-04-01 CN CN202080026711.XA patent/CN113661238A/en active Pending
-
2021
- 2021-09-23 IL IL286630A patent/IL286630A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102655024B1 (en) | 2024-04-04 |
| EP3950938A1 (en) | 2022-02-09 |
| US20220170047A1 (en) | 2022-06-02 |
| IL286630A (en) | 2021-12-01 |
| WO2020204055A1 (en) | 2020-10-08 |
| TW202043478A (en) | 2020-12-01 |
| CN113661238A (en) | 2021-11-16 |
| CA3134705A1 (en) | 2020-10-08 |
| AU2020252840A1 (en) | 2021-11-04 |
| EP3950938A4 (en) | 2023-01-18 |
| BR112021018313A2 (en) | 2021-11-23 |
| MX2021011903A (en) | 2021-10-26 |
| KR20210146362A (en) | 2021-12-03 |
| JPWO2020204055A1 (en) | 2020-10-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11202105109PA (en) | Method for detection of rna | |
| SG11202004455UA (en) | System and method for executing different types of blockchain contracts | |
| IL287468A (en) | Nucleic acid constructs and methods for their manufacture | |
| GB2584946B (en) | Method of selecting ions | |
| GB2586677B (en) | System and method of updating firmware | |
| IL290879A (en) | Method of isolating circulating nucleosomes | |
| GB201804594D0 (en) | Bonegraft substituteand method of manufacture | |
| GB202019942D0 (en) | Waveguide type photodetector and method of manufacture thereof | |
| EP4053284A4 (en) | Method for targeted modification of sequence of plant genome | |
| EP4085931A4 (en) | New method for targeted editing of rna | |
| EP3658674A4 (en) | Method of isolating nucleic acid | |
| GB201802839D0 (en) | Method of manufacture | |
| GB201917694D0 (en) | Enzyme mediated process | |
| IL289032A (en) | Method for decreasing adverse-effects of interferon | |
| IL288353A (en) | Methods of treating cholangiocarcinoma | |
| GB201913196D0 (en) | Culture method | |
| GB201907380D0 (en) | Mediators of gene silencing | |
| IL286630A (en) | Method of introducing target-specific foreign gene | |
| IL287250A (en) | Method of treatment | |
| ZA202106233B (en) | Method of improving sleep | |
| EP4083224A4 (en) | Method for asymmetric amplification of target nucleic acid | |
| GB201902779D0 (en) | Method of screening | |
| GB201914266D0 (en) | Method of amplifying nucleic acids | |
| GB2585449B (en) | Improved pipe and method of production | |
| PL3877516T3 (en) | Method of precipitating phytase |